New study shows genes can predict response to arthritis treatment and paves the way for future drug development
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1
Aleix Prat is leading the research, which focuses on discovering new ways of diagnosing hormone receptor-positive breast cancer, as well as new thera1
Installed in the lobby of the Esther Koplowitz Center (C/ Rosselló, 149-153 Barcelona), the exhibition shows the 15 finalist photographs of the V edi1
Understanding the mechanisms involved in ulcerative colitis and Crohn disease and identifying new therapeutic targets and markers for response to tre1
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioratio1
The activity is part of a new project, initiated this year, aimed to raise awareness of the research done at the Institute on different diseases amon1
Castaño, a researcher in the IDIBAPS group Pathogenesis and Prevention of Diabetes and CIBERDEM, has been recognized for his junior basic research in1
The publication collects the latest advances in neurology since 2002 and in the commemoration of its twentieth anniversary highlights the guidelines1
Both diseases have clinical manifestations that may be similar, but a study, in which IDIBAPS researchers have participated, has identified markers t1